David Moatazedi has served as our President, Chief Executive Officer and as a member of our board of directors, since May 2018. Prior to that time, Mr. Moatazedi was the Senior Vice President at Allergan, Inc., or Allergan, and division head of the U.S. Medical Aesthetics division, which includes facial aesthetics, plastic surgery, regenerative medicine, body contouring, and skin care products from March 2016 to May 2018. From March 2017 to June 2020, Mr. Moatazedi served as a member of the board of directors of Obalon Therapeutics, Inc., a public medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Mr. Moatazedi worked in various leadership capacities within Allergan since March 2005, including as Vice President, Sales and Marketing of the U.S. Facial Aesthetics division from August 2014 to March 2016 and Vice President, Sales and Marketing of the U.S. Plastic Surgery division from February 2013 to August 2014. Prior to Allergan, Mr. Moatazedi was a district manager at Novartis Pharmaceuticals for the Dermatology division. Mr. Moatazedi holds an M.B.A. from Pepperdine University and a B.A. from California State University, Long Beach.

Rui Avelar, M.D. has served as our Chief Medical Officer since January 2014 and was appointed to the additional position of Head of Research and Development in August 2018. From January 2014 to February 2018, Dr. Avelar also served as the Chief Medical Officer of Alphaeon. From March 2011 to December 2013, he served as Chief Medical Officer of Allergan Medical, where he was responsible for clinical development, clinical operations, safety, medical writing, biostatistics and regulatory matters. Dr. Avelar holds a M.D. from the University of Toronto and has received training accreditation in Sports Medicine from the Canadian Academy of Sports Medicine.

Rui Avelar, M.D. has served as our Chief Medical Officer since January 2014 and was appointed to the additional position of Head of Research and Development in August 2018. From January 2014 to February 2018, Dr. Avelar also served as the Chief Medical Officer of Alphaeon. From March 2011 to December 2013, he served as Chief Medical Officer of Allergan Medical, where he was responsible for clinical development, clinical operations, safety, medical writing, biostatistics and regulatory matters. Dr. Avelar holds a M.D. from the University of Toronto and has received training accreditation in Sports Medicine from the Canadian Academy of Sports Medicine.

Tomoko Yamagishi-Dressler has served as our Chief Marketing Officer since 2023. Previously, she was Global Chief Marketing Officer at Beautyblender where she elevated their global market position and drove category leadership for the brand’s namesake makeup tool in Sephora and ULTA stores across the United States. From 2000 to 2020, Tomoko held increasing roles of responsibility at Shiseido, one of the world’s top 10 beauty companies. Earlier in her career, she worked at Chanel Inc. and Victoria’s Secret Beauty Company. With extensive experience in global finance, she has also managed client portfolios for top financial institutions as the former VP of Fixed Income at Lehman Brothers. Tomoko holds an M.B.A. from Harvard Business School and now serves on the Women’s Alumnae Board.

Kurt Knab joined Evolus in August 2018 as Vice President of Sales. Prior to Evolus, Kurt served as VP of Sales at Medline Industries, a privately held manufacturer and distributor of medical supplies. Before Medline, Mr. Knab held multiple sales leadership roles at Lifecell Corporation culminating in VP of Sales. Mr. Knab has more than two decades of experience in the medical and aesthetic industries. He earned his B.S. in Marketing from Pennsylvania State University.

José Bimont is a senior marketing executive at Evolus with a proven track record of success across consumer, medical device, and pharmaceutical industries. With extensive experience leading high-profile brands, José is responsible for driving the development and execution of strategic marketing initiatives that generate sustainable revenue pipelines and maximize market share growth and brand exposure. At Evolus, José is charged with spearheading business model innovation, launching new products, and revitalizing established brands. He is highly skilled at managing turnaround situations within omnichannel and international environments, making him a key player in adapting strategies to dynamic market conditions. Recognized as a top-performing omnichannel expert, he has successfully led initiatives for renowned brands such as Acuvue, Neutrogena, Aveeno, Listerine, Tylenol, Botox, and Medtronic.

Sandra Beaver has served as our Chief Financial Officer since September 2022. From October 2019 to September 2022, Mrs. Beaver served as Senior Vice President of Finance at Experian, a global information services company, where she was responsible for half of company’s North America B2B business units. From November 2002 to September 2019, Mrs. Beaver held roles with increasing levels of responsibility and scope including Vice President of Consolidated Financial Planning & Analysis, and Vice President and Chief Financial Officer at Game Technology PLC. Mrs. Beaver holds a B.A. from the Isenberg School of Management at the University of Massachusetts Amherst.

David Moatazedi has served as our President, Chief Executive Officer and as a member of our board of directors, since May 2018. Prior to that time, Mr. Moatazedi was the Senior Vice President at Allergan, Inc., or Allergan, and division head of the U.S. Medical Aesthetics division, which includes facial aesthetics, plastic surgery, regenerative medicine, body contouring, and skin care products from March 2016 to May 2018. From March 2017 to June 2020, Mr. Moatazedi served as a member of the board of directors of Obalon Therapeutics, Inc., a public medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Mr. Moatazedi worked in various leadership capacities within Allergan since March 2005, including as Vice President, Sales and Marketing of the U.S. Facial Aesthetics division from August 2014 to March 2016 and Vice President, Sales and Marketing of the U.S. Plastic Surgery division from February 2013 to August 2014. Prior to Allergan, Mr. Moatazedi was a district manager at Novartis Pharmaceuticals for the Dermatology division. Mr. Moatazedi holds an M.B.A. from Pepperdine University and a B.A. from California State University, Long Beach.

David Moatazedi has served as our President, Chief Executive Officer and as a member of our board of directors, since May 2018. Prior to that time, Mr. Moatazedi was the Senior Vice President at Allergan, Inc., or Allergan, and division head of the U.S. Medical Aesthetics division, which includes facial aesthetics, plastic surgery, regenerative medicine, body contouring, and skin care products from March 2016 to May 2018. From March 2017 to June 2020, Mr. Moatazedi served as a member of the board of directors of Obalon Therapeutics, Inc., a public medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Mr. Moatazedi worked in various leadership capacities within Allergan since March 2005, including as Vice President, Sales and Marketing of the U.S. Facial Aesthetics division from August 2014 to March 2016 and Vice President, Sales and Marketing of the U.S. Plastic Surgery division from February 2013 to August 2014. Prior to Allergan, Mr. Moatazedi was a district manager at Novartis Pharmaceuticals for the Dermatology division. Mr. Moatazedi holds an M.B.A. from Pepperdine University and a B.A. from California State University, Long Beach.

Rui Avelar, M.D. has served as our Chief Medical Officer since January 2014 and was appointed to the additional position of Head of Research and Development in August 2018. From January 2014 to February 2018, Dr. Avelar also served as the Chief Medical Officer of Alphaeon. From March 2011 to December 2013, he served as Chief Medical Officer of Allergan Medical, where he was responsible for clinical development, clinical operations, safety, medical writing, biostatistics and regulatory matters. Dr. Avelar holds a M.D. from the University of Toronto and has received training accreditation in Sports Medicine from the Canadian Academy of Sports Medicine.

Tomoko Yamagishi-Dressler has served as our Chief Marketing Officer since 2023. Previously, she was Global Chief Marketing Officer at Beautyblender where she elevated their global market position and drove category leadership for the brand’s namesake makeup tool in Sephora and ULTA stores across the United States. From 2000 to 2020, Tomoko held increasing roles of responsibility at Shiseido, one of the world’s top 10 beauty companies. Earlier in her career, she worked at Chanel Inc. and Victoria’s Secret Beauty Company. With extensive experience in global finance, she has also managed client portfolios for top financial institutions as the former VP of Fixed Income at Lehman Brothers. Tomoko holds an M.B.A. from Harvard Business School and now serves on the Women’s Alumnae Board.

Sandra Beaver has served as our Chief Financial Officer since September 2022. From October 2019 to September 2022, Mrs. Beaver served as Senior Vice President of Finance at Experian, a global information services company, where she was responsible for half of company’s North America B2B business units. From November 2002 to September 2019, Mrs. Beaver held roles with increasing levels of responsibility and scope including Vice President of Consolidated Financial Planning & Analysis, and Vice President and Chief Financial Officer at Game Technology PLC. Mrs. Beaver holds a B.A. from the Isenberg School of Management at the University of Massachusetts Amherst.

Kurt Knab joined Evolus in August 2018 as Vice President of Sales. Prior to Evolus, Kurt served as VP of Sales at Medline Industries, a privately held manufacturer and distributor of medical supplies. Before Medline, Mr. Knab held multiple sales leadership roles at Lifecell Corporation culminating in VP of Sales. Mr. Knab has more than two decades of experience in the medical and aesthetic industries. He earned his B.S. in Marketing from Pennsylvania State University.